Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts

Sarah C. Conner, Laurent Benayoun, Jayandra J. Himali, Stephanie L. Adams, Qiong Yang, Charles DeCarli, Jan K. Blusztajn, Alexa Beiser, Sudha Seshadri, Ivana Delalle

Research output: Contribution to journalArticle

Abstract

Genome-wide association studies identified a single nucleotide polymorphism (SNP) in the MSRB3 gene encoding Methionine Sulfoxide Reductase-B3 (MsrB3) to be associated with the risk for low hippocampal volume and late onset Alzheimer's disease (AD). Subsequently, we identified AD-associated abnormal patterns of neuronal and vascular MsrB3 expression in postmortem hippocampi. The present study investigated the relationship between the MSRB3 SNP rs61921502, G (minor/risk allele) and MRI measures of brain injury including total brain volume, hippocampal volume, and white matter hyperintensities using linear regression models; the presence of brain infarcts using logistic regression models; and the incidence of stroke, dementia, and AD using Cox proportional hazards models in 2,038 Framingham Heart Study Offspring participants with MRI administered close to examination cycle 7 (1998-2001). Participants with neurological conditions that impede evaluation of vascular pathology by MRI, i.e., brain tumors, multiple sclerosis, and major head trauma, were excluded from the study. When adjusted for age and age squared at MRI exam, sex, and presence of Apolipoprotein ϵ4 allele (APOE4), individuals with MSRB3 rs61921502 minor allele had increased odds for brain infarcts on MRI compared to those with no minor allele. However, in stratified analyses, MSRB3 rs61921502 minor allele was significantly associated with increased odds for MRI brain infarcts only in the absence of APOE4.

Original languageEnglish (US)
Pages (from-to)357-365
Number of pages9
JournalJournal of Alzheimer's Disease
Volume68
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Alzheimer Disease
Alleles
Brain
Apolipoproteins
Single Nucleotide Polymorphism
Blood Vessels
Linear Models
Logistic Models
Genome-Wide Association Study
Craniocerebral Trauma
Proportional Hazards Models
Brain Neoplasms
Brain Injuries
Multiple Sclerosis
Dementia
methionine sulfoxide reductase
Hippocampus
Stroke
Pathology
Incidence

Keywords

  • Framingham Heart Study
  • hippocampus
  • MSRB3
  • vascular pathology

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts. / Conner, Sarah C.; Benayoun, Laurent; Himali, Jayandra J.; Adams, Stephanie L.; Yang, Qiong; DeCarli, Charles; Blusztajn, Jan K.; Beiser, Alexa; Seshadri, Sudha; Delalle, Ivana.

In: Journal of Alzheimer's Disease, Vol. 68, No. 1, 01.01.2019, p. 357-365.

Research output: Contribution to journalArticle

Conner, SC, Benayoun, L, Himali, JJ, Adams, SL, Yang, Q, DeCarli, C, Blusztajn, JK, Beiser, A, Seshadri, S & Delalle, I 2019, 'Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts', Journal of Alzheimer's Disease, vol. 68, no. 1, pp. 357-365. https://doi.org/10.3233/JAD-180977
Conner, Sarah C. ; Benayoun, Laurent ; Himali, Jayandra J. ; Adams, Stephanie L. ; Yang, Qiong ; DeCarli, Charles ; Blusztajn, Jan K. ; Beiser, Alexa ; Seshadri, Sudha ; Delalle, Ivana. / Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts. In: Journal of Alzheimer's Disease. 2019 ; Vol. 68, No. 1. pp. 357-365.
@article{64a9b919b1064dbf9792435577656905,
title = "Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts",
abstract = "Genome-wide association studies identified a single nucleotide polymorphism (SNP) in the MSRB3 gene encoding Methionine Sulfoxide Reductase-B3 (MsrB3) to be associated with the risk for low hippocampal volume and late onset Alzheimer's disease (AD). Subsequently, we identified AD-associated abnormal patterns of neuronal and vascular MsrB3 expression in postmortem hippocampi. The present study investigated the relationship between the MSRB3 SNP rs61921502, G (minor/risk allele) and MRI measures of brain injury including total brain volume, hippocampal volume, and white matter hyperintensities using linear regression models; the presence of brain infarcts using logistic regression models; and the incidence of stroke, dementia, and AD using Cox proportional hazards models in 2,038 Framingham Heart Study Offspring participants with MRI administered close to examination cycle 7 (1998-2001). Participants with neurological conditions that impede evaluation of vascular pathology by MRI, i.e., brain tumors, multiple sclerosis, and major head trauma, were excluded from the study. When adjusted for age and age squared at MRI exam, sex, and presence of Apolipoprotein ϵ4 allele (APOE4), individuals with MSRB3 rs61921502 minor allele had increased odds for brain infarcts on MRI compared to those with no minor allele. However, in stratified analyses, MSRB3 rs61921502 minor allele was significantly associated with increased odds for MRI brain infarcts only in the absence of APOE4.",
keywords = "Framingham Heart Study, hippocampus, MSRB3, vascular pathology",
author = "Conner, {Sarah C.} and Laurent Benayoun and Himali, {Jayandra J.} and Adams, {Stephanie L.} and Qiong Yang and Charles DeCarli and Blusztajn, {Jan K.} and Alexa Beiser and Sudha Seshadri and Ivana Delalle",
year = "2019",
month = "1",
day = "1",
doi = "10.3233/JAD-180977",
language = "English (US)",
volume = "68",
pages = "357--365",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts

AU - Conner, Sarah C.

AU - Benayoun, Laurent

AU - Himali, Jayandra J.

AU - Adams, Stephanie L.

AU - Yang, Qiong

AU - DeCarli, Charles

AU - Blusztajn, Jan K.

AU - Beiser, Alexa

AU - Seshadri, Sudha

AU - Delalle, Ivana

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Genome-wide association studies identified a single nucleotide polymorphism (SNP) in the MSRB3 gene encoding Methionine Sulfoxide Reductase-B3 (MsrB3) to be associated with the risk for low hippocampal volume and late onset Alzheimer's disease (AD). Subsequently, we identified AD-associated abnormal patterns of neuronal and vascular MsrB3 expression in postmortem hippocampi. The present study investigated the relationship between the MSRB3 SNP rs61921502, G (minor/risk allele) and MRI measures of brain injury including total brain volume, hippocampal volume, and white matter hyperintensities using linear regression models; the presence of brain infarcts using logistic regression models; and the incidence of stroke, dementia, and AD using Cox proportional hazards models in 2,038 Framingham Heart Study Offspring participants with MRI administered close to examination cycle 7 (1998-2001). Participants with neurological conditions that impede evaluation of vascular pathology by MRI, i.e., brain tumors, multiple sclerosis, and major head trauma, were excluded from the study. When adjusted for age and age squared at MRI exam, sex, and presence of Apolipoprotein ϵ4 allele (APOE4), individuals with MSRB3 rs61921502 minor allele had increased odds for brain infarcts on MRI compared to those with no minor allele. However, in stratified analyses, MSRB3 rs61921502 minor allele was significantly associated with increased odds for MRI brain infarcts only in the absence of APOE4.

AB - Genome-wide association studies identified a single nucleotide polymorphism (SNP) in the MSRB3 gene encoding Methionine Sulfoxide Reductase-B3 (MsrB3) to be associated with the risk for low hippocampal volume and late onset Alzheimer's disease (AD). Subsequently, we identified AD-associated abnormal patterns of neuronal and vascular MsrB3 expression in postmortem hippocampi. The present study investigated the relationship between the MSRB3 SNP rs61921502, G (minor/risk allele) and MRI measures of brain injury including total brain volume, hippocampal volume, and white matter hyperintensities using linear regression models; the presence of brain infarcts using logistic regression models; and the incidence of stroke, dementia, and AD using Cox proportional hazards models in 2,038 Framingham Heart Study Offspring participants with MRI administered close to examination cycle 7 (1998-2001). Participants with neurological conditions that impede evaluation of vascular pathology by MRI, i.e., brain tumors, multiple sclerosis, and major head trauma, were excluded from the study. When adjusted for age and age squared at MRI exam, sex, and presence of Apolipoprotein ϵ4 allele (APOE4), individuals with MSRB3 rs61921502 minor allele had increased odds for brain infarcts on MRI compared to those with no minor allele. However, in stratified analyses, MSRB3 rs61921502 minor allele was significantly associated with increased odds for MRI brain infarcts only in the absence of APOE4.

KW - Framingham Heart Study

KW - hippocampus

KW - MSRB3

KW - vascular pathology

UR - http://www.scopus.com/inward/record.url?scp=85062857515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062857515&partnerID=8YFLogxK

U2 - 10.3233/JAD-180977

DO - 10.3233/JAD-180977

M3 - Article

VL - 68

SP - 357

EP - 365

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -